# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jim Thorpe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML011-SYN
- Date: 2026-10-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nolan Fairbanks, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Four months after surgery: lip and neck surveillance, coronary disease review, and screening results. **S**

## History of present illness

Mr. Thorpe returns three weeks after his preventive visit, about four months after his lip surgery. He has done 30 of his 36 cardiac rehabilitation sessions and has had no angina. His low-dose CT of the chest showed a 4 mm smooth nodule in the right lower lobe, read as benign-appearing (Lung-RADS category 2), and coronary artery calcification, as expected with his heart disease. The stool immunochemical test was negative, and his HIV, hepatitis C and hepatitis B tests were negative. He registered with the urban Indian health program near his home and had his first dental check-up there last week; the dentist found no problems in his mouth. He has no new lip or mouth sores and no neck lumps. **S**

| Element | Detail |
|---|---|
| Cardiac rehabilitation | 30 of 36 sessions; no angina |
| Low-dose chest CT | 4 mm benign-appearing nodule (Lung-RADS 2); coronary calcification |
| Other results | Stool test, HIV, hepatitis C and hepatitis B negative |
| Dental check-up | Done through the urban Indian health program; normal |
| Lip | No new sore; no neck lumps |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Ears, nose, mouth, and throat | Negative | No lip or mouth sores; no trouble swallowing |
| Respiratory | Negative | No cough or blood in sputum |
| Cardiovascular | Negative | No chest tightness or leg swelling |
| Integumentary | Positive | Rough spots on the backs of both hands, as found at the preventive visit |

4 systems reviewed. **S**

## Current medications

- Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeated every 5 minutes up to 3 tablets **S**
- Ezetimibe 10 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 60 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 91 kg; BMI 26.6 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Immunizations given today

- Tdap vaccine **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 122/76, pulse 60; weight 91.0 kg |
| Head and neck | Lip scar soft and flat; no nodularity, ulcer or new lesion; mouth, tongue and floor of mouth normal; no neck nodes |
| Skin | Two actinic keratoses on the backs of the hands, treated with liquid nitrogen today |
| Cardiovascular | Regular rhythm; no murmur |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Squamous cell carcinoma of the left lower lip, excised** (C00.1). No recurrence about four months after excision; dental check-up normal. **S**
   - Lip, mouth and neck examination every 1 to 3 months for the rest of the first year.
   - Continue sun protection.
2. **Chronic coronary disease with stable angina** (I25.119). No angina; blood pressure 122/76; LDL at goal last month. Coronary calcification on the screening CT is expected and does not change treatment. **S**
   - Continue current medicines.
   - Finish rehabilitation, then exercise at home or at the community gym most days.
   - Review every 4 to 6 months.
3. **Actinic keratoses** (L57.0). Two lesions on the backs of the hands treated with cryotherapy. **S**
   - Blistering and crusting expected for one to two weeks.
   - Recheck at the next visit; biopsy any lesion that does not clear.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Examination of the lips, mouth, and neck | Every 1 to 3 months in year 1, 2 to 6 months in year 2, 4 to 8 months in years 3 to 5, then yearly | Completed today | No recurrence or new lesion; no neck nodes |
| Imaging | Imaging of the primary site and neck | Before treatment as indicated; afterwards only for symptoms or findings | Not indicated | No symptoms or findings |
| Imaging | Low-dose CT of the chest (second primary and lung cancer screening) | Yearly for eligible former smokers | Completed today | 4 mm benign-appearing nodule, Lung-RADS 2; next screening CT in one year |
| Self-management | Sun protection of the lips and skin | Every visit | Completed today | Daily lip balm with sunscreen and a hat |
| Self-management | Tobacco and alcohol use | Every visit | Completed today | Tobacco-free; AUDIT-C 2 at the preventive visit |
| Referral | Dental evaluation | After diagnosis, then routine | Completed today | First check-up last week through the urban Indian health program, at his choice; normal |
| Examination | Blood pressure (goal below 130/80) | Every visit | Completed today | 122/76, at goal |
| Examination | Weight, BMI, and physical activity | Every visit | Completed today | 91.0 kg, BMI 26.6, down 3 kg since June |
| Survey | Angina frequency and nitroglycerin use | Every visit | Completed today | None |
| Medication safety | Adherence and side effects: aspirin, high-intensity statin, beta-blocker | Every visit | Completed today | All taken daily; no side effects |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing lipid therapy, then every 3 to 12 months; goal LDL below 55 mg/dL | Up to date | LDL 51 mg/dL five weeks ago; next in 6 to 12 months |
| Referral | Cardiac rehabilitation | After a heart attack or for stable angina: up to 36 sessions | Completed today | 30 of 36 sessions |
| Survey | Depression screen (PHQ-2 or PHQ-9) | Yearly | Up to date | PHQ-2 0 at the preventive visit |
| Self-management | Influenza and COVID-19 vaccination review | Yearly | Completed today | Influenza vaccine given at the preventive visit; Tdap given today; COVID-19 vaccine declined for now |

## Goal progress

- Lip cancer removed with clear margins and no recurrence on surveillance through four months. Outcome by 2026-10-26: Excised with clear margins; no recurrence or neck nodes at four months. **S**
- LDL cholesterol below 55 mg/dL on secondary prevention. Outcome by 2026-09-21: LDL 51 mg/dL on atorvastatin 80 mg and ezetimibe 10 mg. **S**
- Blood pressure below 130/80 mmHg. Outcome by 2026-09-21: 124/76 on metoprolol. **S**
- Complete cardiac rehabilitation and walk uphill without angina. Outcome by 2026-10-26: 30 of 36 sessions done; no angina and no nitroglycerin use for two months. **S**
- Stay tobacco-free and protect his lips and skin from the sun. Outcome by 2026-10-26: Tobacco-free; lip balm with sunscreen and a hat used daily. **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026), National Comprehensive Cancer Network
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology (Circulation)
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018), American Heart Association and American College of Cardiology (Circulation)
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease monograph (2026), Aether Forge
- Lung Cancer: Screening (2021), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention

## Follow-up

- Lip surveillance and coronary disease review in two to three months. Second zoster vaccine dose then. Low-dose CT and stool test in one year. **S**

